1st Quarter - Report
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the development and approval of rare disease treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSANNA AGUIRRE HASTINGS New | — |
| CATE MCCANLESS | — |
Insurance INS
Issues related to the development and approval of rare disease treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSANNA AGUIRRE HASTINGS New | — |
| CATE MCCANLESS | — |
Medicare/Medicaid MMM
Issues related to the development and approval of rare disease treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSANNA AGUIRRE HASTINGS New | — |
| CATE MCCANLESS | — |
Pharmacy PHA
Issues related to the development and approval of rare disease treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSANNA AGUIRRE HASTINGS New | — |
| CATE MCCANLESS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.